Clinical Trial

To Evaluate the Adhesion of TK-254RX on Healthy Participants

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated January 28, 2026 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is a single-center, open-label, multiple-dose trial in healthy participants. The primary purpose of this study is to assess the adhesion of TK-254RX. Secondary purposes are to assess the safety of TK-254RX and the residual amount of the patch.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-15.
Status change: Not Yet Recruiting → Recruiting 2026-01-27
Trial Details
NCT Number NCT07307794
Lead Sponsor Teikoku Seiyaku Co., Ltd.
Collaborators: SocraTec R&D GmbH, SocraMetrics GmbH, HWI pharma services GmbH, Clinsearch GmbH, CRM Biometrics GmbH
Conditions Healthy Participants
Enrollment 90 participants
Start Date 2026-01-19
Primary Completion 2026-03 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2026-01-28